Citation: M. Canal et al., A NEW ORAL FORMULATION OF TIAPRIDE (DROPS) - PHARMACOKINETIC PROFILE AND THERAPEUTIC APPLICATIONS, Clinical drug investigation, 15(5), 1998, pp. 455-460
Authors:
BUZELIN JM
DELAUCHECAVALLIER MC
ROTH S
GEFFRIAUDRICOUARD C
SANTONI JP
Citation: Jm. Buzelin et al., CLINICAL UROSELECTIVITY - EVIDENCE FROM PATIENTS TREATED WITH SLOW-RELEASE ALFUZOSIN FOR SYMPTOMATIC BENIGN PROSTATIC OBSTRUCTION, British Journal of Urology, 79(6), 1997, pp. 898-904
Citation: Jp. Santoni et S. Saubadu, ADVERSE EVENTS ASSOCIATED WITH NEUROLEPTIC DRUGS - FOCUS ON NEUROENDOCRINE REACTIONS, Acta therapeutica, 21(3-4), 1995, pp. 193-204
Authors:
GANZONI E
SANTONI JP
CHEVILLARD V
SEBILLE M
MATHY B
Citation: E. Ganzoni et al., ZOLPIDEM IN INSOMNIA - A 3-YEAR POSTMARKETING SURVEILLANCE STUDY IN SWITZERLAND, Journal of international medical research, 23(1), 1995, pp. 61-73
Authors:
BODEN WE
SCHELDEWAERT R
WALTERS EG
WHITEHEAD A
COLTART DJ
SANTONI JP
BELGRAVE G
STARKEY IR
Citation: We. Boden et al., DESIGN OF A PLACEBO-CONTROLLED CLINICAL-TRIAL OF LONG-ACTING DILTIAZEM AND ASPIRIN VERSUS ASPIRIN ALONE IN PATIENTS RECEIVING THROMBOLYSIS WITH A FIRST ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 75(16), 1995, pp. 1120-1123
Citation: C. Trillou et al., COMPARATIVE GASTRIC TOLERABILITY OF LYSINE ACETYLSALICYLATE AND CONVENTIONAL ASPIRIN IN THE DOG, Drug investigation, 7(6), 1994, pp. 323-330